MaaT Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.87	20.15	24.28	35.25	43.31
Short-Term Investments	-	-	-	0.06	-
Cash & Short-Term Investments	24.87	20.15	24.28	35.31	43.31
Cash Growth	23.39%	-16.99%	-31.24%	-18.46%	117.47%
Accounts Receivable	5.19	5.03	5.16	4.24	2.39
Other Receivables	1.63	1.12	1.04	0.78	0.98
Receivables	6.82	6.15	6.21	5.02	3.37
Inventory	0.08	0.06	0.19	0.05	0.03
Prepaid Expenses	1.05	1.07	1.13	1.58	0.43
Other Current Assets	0.18	0.21	0.19	0.16	0.13
Total Current Assets	32.99	27.64	31.99	42.12	47.27
Property, Plant & Equipment	7.34	8.6	9.17	0.97	1.11
Long-Term Investments	-	-	-	-	0.1
Other Intangible Assets	1.84	1.77	1.34	1.2	0.81
Long-Term Deferred Charges	2	-	-	-	-
Other Long-Term Assets	-	0.2	0.2	0.3	-
Total Assets	44.55	38.5	42.93	44.73	49.42
Accounts Payable	11.81	8.83	6.35	4.51	2.47
Accrued Expenses	1.86	1.99	1.29	1.24	0.69
Current Portion of Long-Term Debt	1.16	1.85	2.22	2.77	1.06
Current Portion of Leases	1.34	1.28	1.23	0.21	0.19
Current Income Taxes Payable	0.08	0.09	0.06	0.05	0.03
Current Unearned Revenue	0.21	-	-	-	-
Other Current Liabilities	0.52	0.53	0.37	0.44	0.25
Total Current Liabilities	16.98	14.56	11.52	9.22	4.7
Long-Term Debt	11.26	8.11	5.75	7.94	3.98
Long-Term Leases	3.69	4.72	4.88	0.43	0.57
Pension & Post-Retirement Benefits	0.21	0.17	0.17	0.1	0.12
Other Long-Term Liabilities	10.62	0.6	0.15	0.23	0.19
Total Liabilities	42.75	28.17	22.47	17.92	9.56
Common Stock	1.89	1.4	1.16	0.99	0.99
Additional Paid-In Capital	28.77	35.48	37.38	38.32	46.46
Retained Earnings	-28.65	-26.3	-17.86	-12.37	-7.6
Treasury Stock	-0.21	-0.23	-0.22	-0.14	-
Shareholders' Equity	1.8	10.34	20.47	26.81	39.86
Total Liabilities & Equity	44.55	38.5	42.93	44.73	49.42
Total Debt	17.44	15.96	14.08	11.36	5.81
Net Cash (Debt)	7.43	4.2	10.21	23.95	37.5
Net Cash Growth	76.96%	-58.87%	-57.39%	-36.13%	171.00%
Net Cash Per Share	0.47	0.32	0.90	2.42	15.45
Filing Date Shares Outstanding	18.84	16.08	11.6	11.54	9.89
Total Common Shares Outstanding	18.82	13.95	11.59	9.94	9.88
Working Capital	16.02	13.08	20.47	32.91	42.57
Book Value Per Share	0.10	0.74	1.77	2.70	4.03
Tangible Book Value	-0.05	8.57	19.12	25.61	39.05
Tangible Book Value Per Share	-0.00	0.61	1.65	2.58	3.95
Machinery	1.11	1.35	1.24	0.99	0.73
Construction In Progress	0.74	0.56	0.52	0.07	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.